Gvh-459 File

: Typically develops within the first 100 days; affects the skin (rashes), liver (jaundice), and GI tract (diarrhea).

In medical literature, "GVH-459" or "459" often refers to specific patient cohorts or data points within larger studies on bone marrow transplants. GVH-459

: Modern treatments like post-transplant cyclophosphamide (PTCy) are used to prevent severe cases. : Typically develops within the first 100 days;